Joe Rogan Apologizes Amid Spotify’s Vaccine Controversy
(Bloomberg) -- Joe Rogan pledged more balance and better research for his podcast in an apology aimed at quelling growing controversy about misleading coronavirus information that plunged Spotify Technology SA into controversy last week.
“If I've p----ed you off, I'm sorry,” Rogan said in an Instagram video, while also thanking listeners who have enjoyed his podcast. He said he would “try harder to get people with differing opinions on right afterward” and “do my best to make sure I have researched these topics, the controversial ones in particular, and have all the pertinent facts at hand before I discuss them.”
Read More: Joe Rogan brings the misinformation debate to podcasting
The comments come after Spotify published its existing rules governing content, and said it would add a content advisory to any podcast episode that includes a discussion about Covid-19. The streaming giant has faced mounting pressure from some users and musicians concerned about the veracity of virus information being spread by the platform's most popular podcaster.
Shares of Spotify rose as much as 13% to $196.06 in New York. The stock has regained all of the value it lost last week after folk-rocker Neil Young demanded the company stop airing Rogan's show.
Young and Joni Mitchell pulled their music from Spotify last week in protest of Rogan, who has hosted several outspoken skeptics of the Covid-19 vaccines. The company created rules governing acceptable content on its service years ago and built a hub with coronavirus information early in the pandemic, but hadn't made them public until Sunday.
“I want to thank Spotify for being so supportive during this time and I'm very sorry that this is happening to them and that they are taking so much heat from it,” Rogan said.
©2022 Bloomberg L.P.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.